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Abstract
Masked hypertension is associated with increased risk for cardiovascular disease. Identifying 
modifiable risk factors for masked hypertension could provide approaches to reduce its prevalence. 
Life’s Simple 7 is a measure of cardiovascular health developed by the American Heart 
Association that includes body mass index, physical activity, diet, cigarette smoking, blood 
pressure (BP), cholesterol, and glucose. We examined the association between cardiovascular 
health and masked daytime hypertension in the Jackson Heart Study, an exclusively African-
American cohort. Life’s Simple 7 factors were assessed during a study visit and categorized as 
poor, intermediate, or ideal. Ambulatory BP monitoring was performed following the study visit. 
Using BP measured between 10am and 8pm on ABPM, masked daytime hypertension was defined 
as mean clinic systolic/diastolic BP (SBP/DBP) <140/90 mmHg and mean daytime SBP/DBP 
≥135/85 mmHg. Among the 758 participants with SBP/DBP<140/90 mmHg, 30.5% had masked 
daytime hypertension. The multivariable-adjusted prevalence ratios for masked daytime 
hypertension comparing participants with 2, 3 and ≥4 versus ≤1 ideal Life’s Simple 7 factors were 
0.99 (95%CI: 0.74–1.33), 0.77 (95%CI: 0.57–1.03) and 0.51 (95%CI: 0.33–0.79), respectively. 
Masked daytime hypertension was less common among participants with ideal versus poor levels 
of physical activity (ratio: 0.74, 95% CI: 0.56–1.00), ideal or intermediate levels pooled together 
versus poor diet (prevalence ratio: 0.73, 95% CI: 0.58–0.91), ideal versus poor levels of cigarette 
smoking (prevalence ratio: 0.61, 95% CI: 0.46–0.82), and ideal versus intermediate levels of clinic 
BP (prevalence ratio: 0.28, 95% CI: 0.16–0.48). Better cardiovascular health is associated with a 
lower prevalence of masked hypertension.
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Many adults have high blood pressure (BP) when measured outside of the clinic, despite 
having systolic/diastolic BP (SBP/DBP) <140/90 mmHg based on clinic measurements, a 
condition called masked hypertension.1 In population-based studies, the prevalence of 
masked hypertension has been reported to be between 15% and 30%.2 Masked hypertension 
is associated with a 2-fold higher risk of cardiovascular disease (CVD).3,4 Identifying 
modifiable risk factors for masked hypertension may inform approaches for preventing or 
delaying its onset.
In 2009, the American Heart Association developed the Life’s Simple 7 metric to monitor 
cardiovascular health in the US population.5 This metric is based on seven modifiable health 
factors including body mass index (BMI), physical activity, diet, cigarette smoking, BP, 
cholesterol, and glucose. Several factors that comprise Life’s Simple 7 have individually 
been associated with masked hypertension, but the association between overall 
cardiovascular health and masked hypertension is not well studied.6,7 The objective of this 
analysis was to determine whether adults with better cardiovascular health are less likely to 
have masked hypertension. If a strong association is present, improving cardiovascular 
health may provide a holistic approach to prevent and treat masked hypertension.
METHODS
Study Population
The Jackson Heart Study (JHS) enrolled a population-based cohort of African Americans. It 
was designed to examine CVD risk in African-American men and women. Details of the 
design and conduct of the JHS have been published previously.8,9 Participants were recruited 
from urban and rural areas of 3 counties (Hinds, Madison, and Rankin) that comprise the 
Jackson, Mississippi metropolitan area. The study enrolled 5,301 African Americans 
between 2000 and 2004. Participants were invited to complete a 24-hour ambulatory BP 
monitoring (ABPM) procedure following the baseline examination. A total of 1,146 
participants completed this procedure. For the current analysis, we excluded participants 
with an incomplete ABPM reading (defined below, n=100) and missing data on clinic SBP 
and DBP (n=5). To focus on cardiovascular health in the context of primary prevention, we 
excluded 81 participants with a history of coronary heart disease (CHD) or stroke. As 
masked hypertension can only be present among individuals with clinic-measured SBP <140 
mmHg and DBP < 90 mmHg, we excluded participants with SBP ≥ 140 mmHg or DBP ≥ 90 
mmHg based on measurements obtained during the baseline examination (n=202) for a final 
sample size of 758 participants. The protocol for the JHS, including all procedures, was 
approved by the institutional review boards at the participating institutions. All participants 
provided written informed consent. The current data analysis was approved by the 
institutional review board at the University of Alabama at Birmingham.
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Data for the current analyses were collected by questionnaires, a clinic examination and 
ABPM. Of relevance to the current analysis, data collected through the interview-
administered questionnaires included age, sex, marital status, education, cigarette smoking, 
diet, physical activity, history of stroke and CHD, and self-reported use of antihypertensive, 
antidiabetes or lipid-lowering medication. Data collected during the clinic examination 
included BMI, clinic BP, fasting blood glucose, hemoglobin A1c (HbA1c), and total 
cholesterol.
Life’s Simple 7—The factors that comprise Life’s Simple 7 include BMI, physical 
activity, diet, cigarette smoking, clinic-measured BP, total cholesterol, and fasting glucose. 
These factors were categorized into ideal, intermediate, and poor levels of cardiovascular 
health (Table 1).5 Standing height and weight were measured during the clinic examination. 
These measurements were used to calculate BMI as weight in kilograms divided by height in 
meters squared. Physical activity was assessed using a modified Baecke questionnaire.10 
Diet was assessed using a 158-item food frequency questionnaire (FFQ), which was 
validated in a subset of the JHS cohort.11 The dietary components used in the current 
analysis include fruits and vegetables, fish, whole grains, sodium, and sugary beverages. 
Cigarette smoking status was assessed by the questions “Have you smoked more than 400 
cigarettes in your lifetime?” and “Do you now smoke cigarettes?” Participants were 
categorized as current, former, and never smokers. Clinic BP was measured following a 
standardized protocol, using a Hawksley random zero sphygmomanometer and calibrated to 
a semi-automated oscillatory device as described below. The mean of the two measurements 
was used to define clinic SBP and DBP. Participants were considered to be taking 
antihypertensive medication if they self-reported use of medication to lower BP in the two 
weeks prior to their clinic visit. Participants were asked to fast overnight prior to their clinic 
visit. Fasting blood glucose, HbA1c, and total cholesterol were measured from blood 
samples taken during the clinic examination.9 Participants were considered to be taking 
antidiabetes and lipid-lowering medication based on self-reported use in the two weeks prior 
to their clinic visit.
Clinic BP Measurements—Clinic BP was measured by trained and certified research 
staff at baseline.12 Training was conducted by a study coordinator or blood pressure 
supervisor and included instruction in BP measurement, listening to recordings on 
audiotapes of Korotkoff sounds and live observation of BP measurements. Staff had to pass a 
test in which live recordings were taken simultaneously with the training supervisor using a 
Y-tube stethoscope. Quality control included biannual observation of blood pressure 
measurement by supervisors and frequent staff meetings to provide feedback. 
Recertification, which included live readings with a blood pressure supervisor using a Y-tube 
stethoscope, occurred every six months. Digit preference was also monitored for each staff 
member.
A BP comparability substudy was conducted in which BP was assessed simultaneously, 
using a Y connector, by random zero sphygmomanometer and an Omron HEM-907XL 
device. Since semi-automated devices are commonly used in the clinic setting, the random-
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zero BP measurements were calibrated to a semi-automated device using robust regression 
as described previously.13
Ambulatory BP Measurements—ABPM was performed following the clinic 
examination using a SpaceLabs 90207 device. Measurements were taken every 20 minutes 
during the 24-hour monitoring period. Consistent with the International Database of 
Ambulatory Blood Pressure and Cardiovascular Disease (IDACO), daytime was defined as 
10 am to 8 pm and nighttime was defined as 12 am (midnight) to 6 am.14 For an ABPM 
measurement to be considered complete, participants were required to have at least 10 
daytime and 5 nighttime SBP and DBP measurements.14 On average, participants with a 
complete ABPM had 23 daytime measurements and 17 nighttime measurements.
Masked Hypertension—The primary outcome was masked daytime hypertension. 
Masked nighttime hypertension, masked 24-hour hypertension, and any masked 
hypertension were examined as secondary outcomes. Based on the mean of all 
measurements between 10am and 8pm, daytime hypertension was defined as SBP ≥ 135 
mmHg and/or DBP ≥ 85 mmHg.15 Based on the mean of all measurements between 12am 
and 6pm, nighttime hypertension was defined as SBP ≥ 120 mmHg and/or DBP ≥ 70 
mmHg. Using the mean of all available measurements from ABPM, 24-hour hypertension 
was defined as SBP ≥ 130 mmHg and/or DBP ≥ 80 mmHg.16 As the current study was 
restricted to participants with SBP < 140 mmHg and clinic DBP < 90 mmHg, those with 
daytime, nighttime and 24-hour hypertension had masked daytime, nighttime and 24-hour 
hypertension, respectively. Participants with masked daytime, masked nighttime, or masked 
24-hour hypertension were categorized as having any masked hypertension.
Statistical Analysis
Participant characteristics and the prevalence of masked daytime hypertension were 
calculated by categories defined by the number of ideal Life’s Simple 7 factors (i.e., 0 or 1, 
2, 3, or ≥4 factors). There were too few participants with 0 (n=20), 5 (n=28), 6 (n=4) or 7 
(n=0) ideal Life’s Simple 7 factors to evaluate these groups separately. Poisson regression 
was used to calculate prevalence ratios for masked daytime hypertension associated with 2, 
3, and ≥4 versus 0 or 1 (reference) ideal Life’s Simple 7 factors. Model 1 adjusted for age 
and sex. Model 2 included additional adjustment for education, marital status, and alcohol 
consumption. Model 3 included the variables in Model 2 plus the use of antihypertensive 
medication. Secondary analyses were conducted stratified by antihypertensive medication 
use. Among those not taking antihypertensive medication, there were too few participants 
with 0 or 1 (n=28) ideal Life’s Simple 7 factors to serve as the reference. Therefore, in these 
analyses, participants not taking antihypertensive medication who had 0, 1 or 2 ideal Life’s 
Simple 7 factors were pooled together. We calculated prevalence ratios for any masked 
hypertension, masked nighttime hypertension, and masked 24-hour hypertension associated 
with number of ideal Life’s Simple 7 factors.
Next, we evaluated the association between each Life’s Simple 7 factor with masked 
daytime hypertension. The distribution of poor, intermediate, and ideal health for each of 
Life’s Simple 7 factors was calculated for participants with and without masked daytime 
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hypertension. With the exception of diet and BP, the prevalence and adjusted prevalence 
ratios for masked daytime hypertension associated with intermediate and ideal, versus poor 
(reference) levels of each Life’s Simple 7 factor was calculated using Poisson regression 
models. For diet, participants with ideal and intermediate levels were grouped and compared 
to those with poor diet because there were few participants with an ideal level of diet (n=5). 
For BP, participants in the ideal BP category were compared to those in the intermediate BP 
category because participants with poor BP level (clinic SBP ≥ 140 mmHg or clinic DBP ≥ 
90 mmHg) were excluded from the current analyses. In a final analysis, we calculated a 
Life’s Simple 7 score by assigning each participant 2 points for each factor with an ideal 
level, 1 point for each factor with an intermediate level, and 0 points for each factor with a 
poor level. All 7 factor scores were then summed for a composite score ranging from 0–14 
points. We calculated the prevalence and hazard ratios for masked daytime hypertension, any 
masked hypertension, masked nighttime hypertension, and masked 24-hour hypertension 
associated with the Life’s Simple 7 score, categorized into quartiles (0–6, 7, 8, and 9–14 
points). To account for missing data (Supplemental Table S1), we used multiple imputation 
to replace missing values with a set of plausible values. We conducted 10 imputations using 
chained equations, resulting in 10 data sets, which were combined to obtain an overall 
estimate.17 All analyses were conducted using STATA/IC 13 (Stata Corporation, College 
Station, Texas).
RESULTS
Characteristics of JHS participants with clinic SBP/DBP < 140/90 mm Hg who completed 
and did not complete ABPM are presented in Supplemental Table S2. The mean age of the 
758 participants who completed ABPM and were included in the current analyses was 57.7 
years and 30.1% were male. Participants with more ideal Life’s Simple 7 factors were 
younger and less likely to be taking antihypertensive medication (Table 2). Mean clinic, 
daytime, nighttime, and 24-hour SBP were lower among participants with more ideal Life’s 
Simple 7 factors. No association was present between the number of ideal Life’s Simple 7 
factors and mean clinic, daytime, nighttime, or 24-hour DBP.
Number of Ideal Life’s Simple 7 Factors and Masked Daytime Hypertension
The prevalence of masked daytime hypertension was lower among participants with more 
ideal Life’s Simple 7 factors (Table 3). This association remained present after multivariable 
adjustment. The prevalence ratios for masked daytime hypertension comparing participants 
with 2, 3, ≥4 versus ≤1 ideal Life’s Simple 7 factors were 0.99 (95% CI: 0.74–1.33), 0.77 
(95% CI: 0.57–1.03) and 0.51 (95% CI: 0.33–0.79), respectively, after multivariable 
adjustment. More ideal Life’s Simple 7 factors were associated with lower prevalence ratios 
for masked daytime hypertension among participants taking and not taking antihypertensive 
medication in stratified models (Supplemental Table S3).
Individual Life’s Simple 7 Factors and Masked Daytime Hypertension
Participants with masked daytime hypertension were less likely to have ideal levels of 
physical activity, smoking, clinic BP, cholesterol, or glucose than their counterparts without 
masked daytime hypertension (Figure 1). Having better levels of physical activity, diet, 
Bromfield et al. Page 5













cigarette smoking, and clinic BP were associated with a lower prevalence of masked daytime 
hypertension after each level of adjustment (Table 4). After multivariable adjustment, the 
prevalence ratios for masked daytime hypertension comparing ideal versus poor levels was 
0.86 (95% CI: 0.62–1.19) for cholesterol and 0.86 (95% CI: 0.63–1.17) for glucose.
Number of Ideal Life’s Simple 7 Factors and Any Masked Hypertension, Masked Nighttime 
Hypertension, and Masked 24-hour Hypertension
The prevalence of any masked hypertension, masked nighttime hypertension, or masked 24-
hour hypertension was progressively lower among participants with more ideal Life’s 
Simple 7 factors (Supplemental Table S4). These associations remained present after 
multivariable adjustment.
Life’s Simple 7 Score and Masked Daytime Hypertension
Having a higher Life’s Simple 7 score was associated with a lower prevalence of masked 
daytime hypertension (Supplemental Table S5). After multivariable adjustment, the 
prevalence ratios for masked daytime hypertension were 0.86 (95% CI: 0.66–1.14), 0.67 
(95% CI: 0.48–0.93), and 0.62 (95% CI: 0.43–0.90) for participants with Life’s Simple 7 
scores of 7, 8 and 9 to 14 each compared to scores of 0 to 6. Higher Life’s Simple 7 scores 
were associated with a lower prevalence for any masked hypertension, masked nighttime and 
masked 24-hour hypertension.
DISCUSSION
In the current study, the prevalence of masked daytime hypertension was lower among 
participants with better cardiovascular health as assessed using the Life’s Simple 7 metric. 
Having more physical activity, better diet, not smoking, and having ideal clinic BP were 
each associated with a lower prevalence of masked daytime hypertension. Also, better 
cardiovascular health was associated with a lower prevalence of any masked hypertension, 
masked nighttime hypertension and masked 24-hour hypertension. These data suggest that 
improving modifiable cardiovascular health factors may prevent masked hypertension.
Masked hypertension is associated with an increased risk for CVD.3,18 However, few studies 
have evaluated modifiable factors that may be associated with a reduced prevalence of 
masked hypertension. In a meta-analysis, current smoking (odds ratio: 1.32, 95% CI: 1.13–
1.50) and higher clinic SBP (odds ratio: 1.10, 95% CI: 1.01–1.19 per 1 mmHg higher clinic 
SBP) were associated with an increased prevalence of masked hypertension.19 In contrast, in 
a study of 254 adults, high dietary sodium intake and high fruit and vegetable consumption 
were not associated with masked hypertension.6 This latter study only included 44 
participants with masked hypertension and the association of diet with masked hypertension 
was not investigated after multivariable adjustment. In the current study, better diet, not 
smoking, and lower clinic BP were each associated with a lower prevalence of masked 
daytime hypertension.
Studies have reported associations between having more physical activity and lower glucose 
with masked hypertension.20–22 However, there are few studies evaluating the association of 
cholesterol and masked hypertension. In a study by Hänninen et. al., high cholesterol was 
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not associated with masked hypertension.21 The prevalence ratios in the current study 
suggested a protective association between lower cholesterol and lower glucose and reduced 
prevalence of masked daytime hypertension but these results were not statistically 
significant. The lack of a statistically significant association for masked hypertension with 
cholesterol and glucose may reflect low statistical power to detect these associations in the 
current study.
Having more ideal cardiovascular health factors is associated with a lower risk of 
cardiovascular morbidity and mortality.23,24 However few US adults have ideal 
cardiovascular health, as defined by Life’s Simple 7. Of 12,744 participants from the 
Atherosclerosis Risk in Communities (ARIC) study without a history of CVD, only 0.1% 
had ideal levels of all Life’s Simple 7 factors.23 A low prevalence was also present in 15,647 
US adults in the 2005–2010 National Health and Nutrition Examination Survey (NHANES), 
where only 1.2% of participants had ideal levels for all Life’s Simple 7 factors.25 These data 
suggest that there is a substantial opportunity to improve cardiovascular health among US 
adults.
In the current study, participants with better cardiovascular health had a lower prevalence of 
masked hypertension. In 2011, the Department of Health and Human Services launched a 
national initiative known as the Million Hearts.26 This initiative addresses clinical 
prevention of cardiovascular events and also aims to increase community prevention efforts 
which include reducing smoking, improving nutrition, and reducing BP. Findings from the 
current study suggest that interventions directed towards improving cardiovascular health, 
such as the Million Hearts initiative, may be helpful for lowering the prevalence of masked 
hypertension.
The 2013 European Society of Hypertension and European Society of Cardiology task force 
recommended that both lifestyle and antihypertensive medication be considered in treating 
masked hypertension.15 However, there are no empiric data to support this recommendation. 
The current study supports the use of lifestyle modification by demonstrating the potential 
benefits of better cardiovascular health on masked hypertension. However, randomized 
controlled trials are needed to confirm this finding.
This study has several strengths including the availability of data from a large population-
based sample. Additionally, ABPM and clinic BP were measured following standardized 
protocols. The availability of extensive data allowed us to adjust for potential confounders. 
Despite these strengths, the findings from this study should be interpreted within the context 
of potential limitations. ABPM was only performed in a sub-group of JHS participants 
which resulted in the need to group some of the Life’s Simple 7 categories. Clinic BP was 
measured at a single visit and ABPM was only performed a single time. However, masked 
hypertension has been reported to have a high degree of reproducibility.27,28 Finally, 
physical activity, diet, and cigarette smoking were self-reported and objective measures of 
these factors were not available.
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In the current population-based study, masked daytime, nighttime and 24-hour hypertension 
were less prevalent among participants with better cardiovascular health. Ideal levels of 
physical activity, diet, cigarette smoking, and clinic BP were associated with a lower 
prevalence of masked daytime hypertension. These data suggest that improving 
cardiovascular health may reduce the prevalence of masked hypertension.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Although individual cardiovascular risk factors have been associated 
with masked hypertension in prior studies, there are few data on the 
association between overall cardiovascular health and masked 
hypertension.
• We examined the association between cardiovascular health and 
masked daytime hypertension among a population-based cohort of 
African Americans.
What Is Relevant?
• The prevalence of masked hypertension is 15% to 30%.
• There is a strong association of masked hypertension with CVD events.
• There is a need to identify modifiable risk factors to prevent mask 
hypertension.
Summary
• Having better cardiovascular health was associated with a lower 
prevalence of masked daytime hypertension, masked nighttime 
hypertension, and masked 24-hour hypertension.
• These results suggest the importance of improving cardiovascular 
health to reduce the prevalence of masked hypertension.
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Prevalence of poor, intermediate, and ideal health for each Life’s Simple 7 component 
among Jackson Heart Study participants with and without masked daytime hypertension. 
MHTN indicates masked daytime hypertension, which is defined as non-elevated clinic 
blood pressure and elevated daytime blood pressure; and BMI: body mass index.
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Table 1
Definition of poor, intermediate, and ideal cardiovascular health for each factor of the American Heart 
Association’s Life’s Simple 7
Life’s Simple 7 Factor Poor Health Intermediate Health Ideal Health
Body Mass Index ≥ 30 kg/m2 25–29.9 kg/m2 < 25 kg/m2
Physical Activity
















2 0 < minutes 
of vigorous 
physical 
activity < 75; 
or
























Healthy Diet Score* 0–1 components 2–3 components 4–5 components
Cigarette Smoking Current Quit <12 months ago Never or quit ≥12 months ago
Blood Pressure†
SBP ≥ 140 mmHg or DBP ≥ 90 
mmHg
SBP 120–139 mmHg or DBP 80–89 
mmHg or SBP <120 mmHg and 
DBP <90 mmHg with medication
SBP < 120 mmHg and DBP < 80 
mmHg, without medication
Total Cholesterol ≥ 240 mg/dL 200–239 mg/dL or < 200 mg/dL, with medication <200 mg/dL, without medication
Fasting Blood Glucose†
≥ 126 mg/dL or HbA1c ≥ 6.5% or 
taking diabetes medication
100–125 mg/dL or HbA1c 5.7–6.4%, 
and not taking diabetes medication
<100 mg/dL, HbA1c < 5.7%, and 
not taking diabetes medication
*
Dietary components of the Healthy Diet Score include fruits and vegetable (≥ 4.5 cups per day), fish (≥ 3.5 ounces, twice per week), whole grains 
(≥ 3 servings per day), sodium (< 1,500 mg per day), sugary beverages (≤ 450 kcal per week).
†
Participants who met part of the criterion for poor health in addition to part of the criterion for intermediate health were categorized as having 
poor health.
SBP: systolic blood pressure; DBP: diastolic blood pressure; and HbA1c: Hemoglobin A1c.
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Table 4
Prevalence ratios for masked daytime hypertension associated with each Life’s Simple 7 factor among Jackson 
Heart Study participants.
Life’s Simple 7 Factors
Poor Intermediate Ideal
p-trend
Prevalence ratio (95% CI)
Model 1
 BMI 1 (ref) 1.14 (0.90–1.45) 1.18 (0.86–1.61) 0.221
 Physical Activity 1 (ref) 0.83 (0.65–1.07) 0.78 (0.58–1.05) 0.063
 Diet* 1 (ref) 0.77 (0.61–0.96) 0.023
 Cigarette Smoking 1 (ref) 0.62 (0.17–2.21) 0.63 (0.47–0.85) 0.003
 BP† 1 (ref) 0.28 (0.16–0.47) <0.001
 Cholesterol 1 (ref) 1.03 (0.75–1.42) 0.89 (0.64–1.23) 0.325
 Glucose 1 (ref) 0.80 (0.55–1.16) 0.80 (0.58–1.09) 0.242
Model 2
 BMI 1 (ref) 1.13 (0.89–1.43) 1.18 (0.87–1.61) 0.227
 Physical Activity 1 (ref) 0.82 (0.64–1.05) 0.76 (0.56–1.02) 0.041
 Diet* 1 (ref) 0.76 (0.60–0.95) 0.017
 Cigarette Smoking 1 (ref) 0.60 (0.17–2.15) 0.61 (0.45–0.82) 0.001
 BP† 1 (ref) 0.28 (0.16–0.47) <0.001
 Cholesterol 1 (ref) 1.04 (0.76–1.42) 0.89 (0.64–1.24) 0.347
 Glucose 1 (ref) 0.80 (0.55–1.17) 0.80 (0.59–1.09) 0.244
Model 3
 BMI 1 (ref) 1.17 (0.92–1.48) 1.26 (0.92–1.73) 0.105
 Physical Activity 1 (ref) 0.83 (0.64–1.06) 0.74 (0.56–1.00) 0.031
 Diet* 1 (ref) 0.73 (0.58–0.91) 0.006
 Cigarette Smoking 1 (ref) 0.60 (0.18–2.00) 0.61 (0.46–0.82) 0.001
 BP† 1 (ref) 0.28 (0.16–0.48) <0.001
 Cholesterol 1 (ref) 1.00 (0.73–1.36) 0.86 (0.62–1.19) 0.262
 Glucose 1 (ref) 0.81 (0.56–1.18) 0.86 (0.63–1.17) 0.518
Masked daytime hypertension is defined as mean clinic SBP <140 mmHg and clinic DBP <90 mmHg blood pressure and mean daytime SBP 
and/or daytime DBP ≥135/85 mmHg blood pressure.
*
For diet, the ideal and intermediate categories were combined and compared to poor diet.
†
Individuals with poor blood pressure (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg) were excluded from the analysis based on the definition of masked 
daytime hypertension, making the intermediate category the reference for blood pressure.
CI: confidence interval; BMI: body mass index; BP: blood pressure; SBP: systolic blood pressure; and DBP: diastolic blood pressure.
Model 1 is adjusted for age and sex.
Model 2 is adjusted for variables in Model 1 and education and marital status.
Model 3 is adjusted for variables in Models 1 and 2 and antihypertensive medication use.
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